Johann Altenberger

Efficacy and Safety of the Pulsed Infusions of Levosimendan in Outpatients with Advanced Heart Failure (LevoRep) Study: A Multicentre Randomized Trial

Johann Altenberger, John Parissis, A. Costard-Jaeckle et al. · European Journal of Heart Failure · 2014 · 136 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure

Christina Dückelmann, Friedrich Mittermayer, Dominik G. Haider et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 106 citations · Full text

Medicine, Cardiology, Pharmacology +13

Organization of Heart Failure Management in European Society of Cardiology Member Countries: Survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups

Petar Seferović, Gerasimos Filippatos, Aušra Kavoliūnienė et al. · European Journal of Heart Failure · 2013 · 83 citations · Full text

Medicine, Cardiology, Internal Medicine +11

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

Markku S. Nieminen, Johann Altenberger, Tuvia Ben‐Gal et al. · International Journal of Cardiology · 2014 · 66 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure

Gerhard Poelzl, Johann Altenberger, Richard Pacher et al. · International Journal of Cardiology · 2014 · 64 citations

Pharmacy, Cardiology, Pharmacotherapy +12